Metformin received FDA approval in 1994 for type 2 diabetes and with its beneficial effect on glycated hemoglobin (HbA1c), efficacy, and safety being wellestablished, 3 , 4 , 5 it became the recommended firstline choice for patients with type 2 diabetes in 2005
IV therapy eliminates these absorption barriers completely
Research Grade: All products are clearly marked for research use only to comply with regulatory requirements and institutional research guidelines
Whats your experience with health transformations that go beyond diet and exercise
By confronting these barriers, DDS can transition from conceptual breakthroughs to clinically validated solutions, offering safer, more equitable, and globally accessible therapeutic strategies to reduce the socioeconomic burden of gout and hyperuricemia